To identify potential new therapy options in pediatric low-grade spinal cord tumors, we evaluated whether these tumors identified at 2 institutions (Children’s Hospital Colorado [CHCO] and SickKids) harbor targetable lesions such as the KIAA1549–BRAF fusion and BRAFV600E mutations. Here, BRAF is linked to spinal cord neoplasm.